Castleview Partners, LLC Atossa Therapeutics, Inc. Transaction History

Castleview Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.82 - $1.14 $341 - $475	417 Added 502.41%	500 $0
Q2 2022 Aug 17, 2022	SELL	$0.85 - $1.28 $392 - $591	-462 Reduced 84.77%	83 $0
Q2 2022 Aug 16, 2022	BUY	$0.85 - $1.28 $38 - $57	45 Added 9.0%	545 $0
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $333 - $522	-300 Reduced 37.5%	500 $0
Q4 2021 Feb 17, 2022	BUY	$1.6 - $3.27 $480 - $981	300 Added 60.0%	800 $1,000
Q2 2021 Aug 17, 2021	BUY	$1.52 - $8.62 $760 - $4,310	500 New	500 $3,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $97.5M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.